Company news

Cvs Group Plc (LSE:CVSG) news

Cvs Group Plc news releases on 6ix. Latest, Oct 5, 2026: Transaction in Own Shares

View Cvs Group Plc →

Press releases & updates

Transaction in Own Shares

October 5, 2026

TVR & Confirmation of Dividend Dates

September 30, 2026

Final results for the year ended 30 June 2026

September 24, 2026

Transaction in Own Shares and Total Voting Rights

September 1, 2026

Updated: Transaction in Own Shares

June 8, 2026

Changes to NEDs' Responsibilities

May 26, 2026

CVS : 2025 Annual General Meeting - Voting Results Update Statement

May 15, 2026

CVS : Major refurbishment underway at CVS’ Pet Doctors Woking to improve care for local pets

May 14, 2026

CVS : publishes Quality Improvement and Research Report

May 7, 2026

CVS : CUTTING‑EDGE CANINE MIRACLE! Bristol vets use groundbreaking veterinary implant new to UK

May 6, 2026

CVS : Equine launches major new research study into treatment outcomes for equine glandular gastric disease

May 1, 2026

CVS : Quality Improvement and Research Report (QIReportandResearchReport2026Final)

April 24, 2026

Non-Executive Director Appointment

April 21, 2026

Standard form for notification of major holdings

April 20, 2026

CVS : Local Labrador-cross saved by Bristol Vet Specialists after kitchen mishap

April 8, 2026

Total Voting Rights

March 31, 2026

CEO retirement

March 30, 2026

CVS : Dovecote Veterinary Specialists invests £1 million to elevate pet care across the Midlands

March 26, 2026

Non-Executive Director Changes

March 25, 2026

Response to CMA Summary Final Decision Report

March 24, 2026

CVS : opens new South West training centre to expand clinical development for the veterinary profession

March 6, 2026

Interim Results

February 26, 2026

CVS : Landmark feline cancer study reveals new genetic insights that could transform treatment options for cats

February 19, 2026

CVS : Equine referral hospitals deliver major cuts in isoflurane use and carbon emissions through innovative anaesthesia practices

February 18, 2026

CVS : launches new cancer care service to support veterinary practices

February 4, 2026

Readmission - CVS Group Plc

January 29, 2026

Response to DEFRA consultation

January 28, 2026

Publication of Prospectus and Trading Update

January 23, 2026

Transaction in Own Shares

January 22, 2026

CVS : Chestergates Veterinary Specialists launches Specialist Dermatology Service to expand multidisciplinary care for complex skin and ear disease

January 14, 2026

Block Listing Interim Review

January 12, 2026

CVS : launches Life Stage Assessment Clinical Improvement Project to champion pet wellness

January 7, 2026

Director/PDMR Shareholding

January 6, 2026

CVS : Chestergates Veterinary Specialists strengthens surgical team with appointment of Specialist Matthew Smith

December 18, 2025

Update on move to the Main Market

December 11, 2025

PDMR Dealing

December 8, 2025

CVS : New study reveals key prognostic indicators in canine mast cell tumours

December 2, 2025

SAYE Option Scheme & PDMR Dealing

November 28, 2025

Result of AGM

November 18, 2025

CVS : New £1.58m veterinary practice opens on Broadfield Business Park, Sheffield

November 6, 2025

CVS : unveils ‘CVS Learning Live’ theatre at London Vet Show 2025

October 30, 2025

Commencement of Share Buyback Programme

October 24, 2025

Posting of Annual Report & Notice of AGM

October 17, 2025

Response to CMA provisional decision announcement

October 15, 2025

Final results for the year ended 30 June 2025

October 7, 2025

PDMR Shareholding Correction

September 15, 2025

Holding(s) in Company

September 11, 2025

Notification of major holdings

September 5, 2025

LTIP Awards and PDMR Dealing

August 1, 2025

Full year trading update

July 24, 2025

Older →